Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Clinical and experimental dermatology - 48(2023), 9 vom: 25. Aug., Seite 1055-1056 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Andrew, Kashini [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal |
|---|
| Anmerkungen: |
Date Completed 28.08.2023 Date Revised 28.08.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/ced/llad173 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356493369 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356493369 | ||
| 003 | DE-627 | ||
| 005 | 20231226070558.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/ced/llad173 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1188.xml |
| 035 | |a (DE-627)NLM356493369 | ||
| 035 | |a (NLM)37146158 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Andrew, Kashini |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Sarilumab (interleukin-6 receptor monoclonal antibody) for the treatment of pemphigus vulgaris |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 28.08.2023 | ||
| 500 | |a Date Revised 28.08.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a sarilumab |2 NLM | |
| 650 | 7 | |a NU90V55F8I |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a Receptors, Interleukin-6 |2 NLM | |
| 700 | 1 | |a Dhariwal, Sukhjit K |e verfasserin |4 aut | |
| 700 | 1 | |a Szczecinska, Weronika |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical and experimental dermatology |d 1993 |g 48(2023), 9 vom: 25. Aug., Seite 1055-1056 |w (DE-627)NLM000126810 |x 1365-2230 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2023 |g number:9 |g day:25 |g month:08 |g pages:1055-1056 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/ced/llad173 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2023 |e 9 |b 25 |c 08 |h 1055-1056 | ||